Ostelin

What it is

Ostelin is a complementary medicine brand sponsored by Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare. The brand encompasses multiple formulations including calcium and vitamin D3 combinations, vitamin D3 alone, and specialised blends containing additional nutrients such as magnesium, vitamin K2, glucosamine, chondroitin, and turmeric.

Regulatory history

The first Ostelin product, Ostelin Calcium & Vitamin D3 Chewable, was registered on the ARTG on 26 August 2010. Subsequent formulations expanded the range, including Ostelin Vitamin D3 1000IU (registered 9 August 2012), Ostelin Calcium & Vitamin D3 (registered 15 August 2012), and Ostelin Kids Calcium & Vitamin D3 (registered 24 March 2014). Liquid formulations were introduced, with Ostelin Kids Vitamin D3 Liquid registered on 25 July 2014 and Ostelin Vitamin D3 1000IU Liquid on 13 May 2015. Specialist products followed, including Ostelin Specialist Range Vitamin D 7000IU (registered 7 September 2016) and Ostelin Infant Vitamin D3 drops (registered 5 December 2017). From 2021 onwards, the portfolio expanded significantly with new formulations such as Ostelin Kids Milk Calcium & Vitamin D3 Chewable (registered 19 August 2021), Ostelin Bone Strength + Glucosamine with Chondroitin (registered 5 April 2022), and Ostelin Cal-DK2 (registered 8 March 2023). Recent additions include Ostelin Calcium & Vitamin D3 + Magnesium (registered 14 December 2023), Ostelin Calcium & Vitamin D3 + K2 (registered 22 April 2024), and multiple 2024 registrations including Ostelin Vitamin D3 & Glucosamine + Chondroitin, Ostelin Calcium & Vitamin D3 Minis, Ostelin Iron & B+ Energy, Ostelin Menopause Support, and Ostelin Urinary Tract Health. The brand continues to expand with 2025 and 2026 registrations including Ostelin Vitamin D3 1000IU, Ostelin Vitamin D3 & K2, Ostelin Vitamin K2, Ostelin Vitamin D3 & K2 + Magnesium, and Ostelin Vitamin D3 & Magnesium Glycinate.